Clinical Trial Detail

NCT ID NCT01294826
Title Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Swedish Medical Center
Indications

colorectal cancer

Therapies

Cetuximab + Luminespib

Age Groups: adult

No variant requirements are available.